drugset
drugset / Trial / NCT02300129

Effect of CD07805/47 Gel in Rosacea Flushing

NCT02300129 ↗

Phase 2 Completed 34 enrolled Galderma R&D
RandomizedCrossoverSingle-blindTreatment

Summary

Phase 2a study to assess the efficacy and safety of CD07805/47 0.5% gel in the prevention of the flush of rosacea.

Timeline

Start
2014-04
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 1 g Topical

Indications

rosacea